Stem cell therapies and Parkinson’s – Michael J Fox Foundation webinar

Resources & Tools

Author: Joe McAweaneyPublished: 15 August 2019

Prep: Cook: Serves:

Tune in to the latest webinar in The Michael J Fox Foundation’s Third Thursdays series for an expert discussion on stem cell therapies and its potential treatments for Parkinson’s

The next episode of The Michael J Fox Foundation’s Third Thursdays webinar series will focus on stem cell therapies for Parkinson’s.

In the free hour-long webinar, a panel of Parkinson’s experts will discuss the status of stem cell therapies – and how they could be used to treat Parkinson’s. Panellists will also answer a range of questions on Parkinson’s from listeners.

There has been significant research into Parkinson’s and stem cells therapies, with studies suggesting that genetically edited cells may be able to counter the effects of the condition.

Last year, scientists from Kyoto University, Japan, carried out a world first trial – transplanting reprogrammed stem cells into people with Parkinson’s.

And in January, a team from the University of Edinburgh, UK, created Parkinson’s resistant stem cells. As part of the study, published in the ‘European Journal of Neuroscience’, the team used gene editing techniques to remove the alpha-synuclein protein from stem cells – preventing them from developing the condition.

To listen to this webinar, listeners must register here up to 15 minutes before it’s start time at 12:00 EST. If you cannot make the live broadcast, you can visit the archive to listen to a recording.

Cramping more than your style

Last Month

Next Month

Go Back

Share this story

Comments

Perspectives

Tom Isaacs president of The Cure Parkinson’s Trust has died

"We're devastated but are focusing on his incredible achievements"

Young onset Parkinson’s: “How I look is not how I feel”

The first in our series profiling Parkinson's Vision 2020 speakers

Fynlee Hateley: the 13-year-old Parkinson’s campaigner

The boy has raised UK £1,000 for the condition

Plant-based compounds could treat chronic pain in Parkinson’s, study finds

A six-year study has found that chronic pain in people with Parkinson’s is linked to a gene involved with how the brain responds to cannabis compounds. The investigation examined why some people with the condition experience persistent pain – and the impact it has on their work, daily life and social relationships. Conducted by researchers at Manchester’s Salford Royal Foundation Trust, UK, and funded by Parkinson’s UK, it is the largest study to investigate chronic pain in people with Parkinson’s. Dr Monty Silverdale, consultant neurologist at Greater Manchester Centre, said: “This study is significant because it shows the important role of genetics in chronic pain in Parkinson’s. “Our findings suggest that cannabis-based compounds may be worth investigating as a treatment for pain in Parkinson’s.”

Could playing table tennis help reduce Parkinson’s symptoms?

Researchers at Fukuoka University, Japan, have found that playing table tennis may help alleviate motor symptoms in Parkinson’s. As part of the study, 12 people with Parkinson’s with an average age of 73 played a five-hour session of table tennis every week for a period of six months. The sessions were developed specifically for people with the condition by experienced table tennis players from the university’s department of sports science. The participants were evaluated after three months and at the end of the study. At both evaluations, participants had reduced symptoms – showing improvement in speech, handwriting, walking and hand tremors. Two participants reported side-effects of backache and falling. Study author Ken-ichi Inoue, MD, of Fukuoka University said: “While this study is small, the results are encouraging because they show ping pong, a relatively inexpensive form of therapy, may improve some symptoms of Parkinson’s disease. A much larger study is…

‘Dopamine-boosting’ BT13 molecule could be used to slow Parkinson’s

Researchers have discovered that a molecule called BT13 could have potential to treat Parkinson’s. The study, conducted by scientists from the University of Helsinki, Finland, found that mice injected with the BT13 molecule had an increase in dopamine levels in the brain. Their findings also suggested that the molecule could lead to a new drug treatment to protect the brain cells that produce dopamine. Dopamine helps coordinate movement, but people with Parkinson’s have normally lost between 70 and 80% of the brain cells that produce the neurotransmitter when they are diagnosed with the condition. Professor David Dexter, Deputy Director of Research at Parkinson’s UK – which co-funded the study – said: “People with Parkinson’s desperately need a new treatment that can stop the condition in its tracks, instead of just masking the symptoms. “More research is needed to turn BT13 into a treatment to be tested in clinical trials, to…

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Email
This field is for validation purposes and should be left unchanged.

Stem cell therapies and Parkinson’s – Michael J Fox Foundation webinar

Resources & Tools

Author: Joe McAweaneyPublished: 15 August 2019

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Perspectives

Tom Isaacs president of The Cure Parkinson’s Trust has died

Interviews

Young onset Parkinson’s: “How I look is not how I feel”

Interviews

Fynlee Hateley: the 13-year-old Parkinson’s campaigner

Plant-based compounds could treat chronic pain in Parkinson’s, study finds

Could playing table tennis help reduce Parkinson’s symptoms?

‘Dopamine-boosting’ BT13 molecule could be used to slow Parkinson’s

{title}

Subscribe

Stem cell therapies and Parkinson’s – Michael J Fox Foundation webinar

Resources & Tools

Author: Joe McAweaneyPublished: 15 August 2019

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

Perspectives

Tom Isaacs president of The Cure Parkinson’s Trust has died

Interviews

Young onset Parkinson’s: “How I look is not how I feel”

Interviews

Fynlee Hateley: the 13-year-old Parkinson’s campaigner

Plant-based compounds could treat chronic pain in Parkinson’s, study finds

Could playing table tennis help reduce Parkinson’s symptoms?

‘Dopamine-boosting’ BT13 molecule could be used to slow Parkinson’s

{title}

Subscribe

Sign in